Suzhou Basecare Medical Corporation Limited (2170.HK)
HKD 2.75
(-8.94%)
HKD 2.75
(-8.94%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -267.23 Million | -188.76 Million | -197.85 Million | -64.28 Million | -38.14 Million | -26.69 Million |
| Net Income | -196.31 Million | -117.15 Million | -125.74 Million | -885.35 Million | -536.28 Million | -162.76 Million |
| Depreciation & Amortization | 19.56 Million | 8.38 Million | 5.58 Million | 6.72 Million | 8.37 Million | 8.06 Million |
| Deferred income taxes | - | - | 10.3 Million | - | - | 104.1 Million |
| Stock-based compensation | - | - | 7.9 Million | - | - | 26.97 Million |
| Change in working capital | -42.05 Million | 18.1 Million | -78.96 Million | -22.23 Million | -31 Million | -3.98 Million |
| Other non-cash items | -35.89 Million | -98.1 Million | -16.94 Million | 836.57 Million | 520.77 Million | 913 Thousand |
| Investing Cash Flow | -324.81 Million | -88.69 Million | -56.6 Million | 33.53 Million | 16.76 Million | -54.71 Million |
| Investments in PPE | -104.2 Million | -128.75 Million | -36.86 Million | -8.08 Million | -2.36 Million | -4.58 Million |
| Acquisitions | -261.12 Million | 21.08 Million | -42.47 Million | 15.39 Million | - | -250 Thousand |
| Investment purchases | -1.57 Million | -77.42 Million | - | -30 Million | -212 Million | -65 Million |
| Sales/Maturities of investments | - | 75.41 Million | - | 60.67 Million | 231.05 Million | 15.05 Million |
| Other Investing Activities | 37.27 Million | 20.97 Million | 22.73 Million | -4.45 Million | 71 Thousand | 61 Thousand |
| Financing Cash Flow | 190.55 Million | 23.51 Million | 1.59 Billion | 207.47 Million | 26.49 Million | 82.11 Million |
| Debt repayment | -196.73 Million | -20 Million | -30 Million | -30 Million | -20 Million | -1.99 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 1.67 Billion | - | - | - |
| Other Financing Activities | 5.1 Million | 43.51 Million | -52.68 Million | 237.47 Million | 20 Million | 82.11 Million |
| Accounts receivables | 2.14 Million | -15.06 Million | -46.88 Million | -45.34 Million | -15.81 Million | -1.46 Million |
| Accounts payables | - | 15.06 Million | 46.88 Million | 45.34 Million | 15.81 Million | - |
| Inventory | -21.15 Million | -14.73 Million | -24.09 Million | 4.12 Million | -3.75 Million | -2.39 Million |
| Other working capital | -793 Thousand | 32.84 Million | -54.86 Million | -26.36 Million | -27.25 Million | -1.58 Million |
| Cash at beginning of period | 1.33 Billion | 1.52 Billion | 192.32 Million | 24.15 Million | 19.04 Million | 18.33 Million |
| Cash at end of period | 943.21 Million | 1.33 Billion | 1.52 Billion | 192.32 Million | 24.15 Million | 19.04 Million |
| Capital Expenditure | -104.2 Million | -128.75 Million | -36.86 Million | -8.08 Million | -2.36 Million | -4.58 Million |
| Effect of forex changes on cash | 12.56 Million | 62.9 Million | -10.3 Million | -8.55 Million | - | - |
| Net cash flow / Change in cash | -388.93 Million | -191.04 Million | 1.33 Billion | 168.16 Million | 5.11 Million | 707 Thousand |
| Free Cash Flow | -371.44 Million | -317.52 Million | -234.71 Million | -72.37 Million | -40.5 Million | -31.27 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -196.31 Million | -140.78 Million | -69.4 Million | -110.62 Million | -117.15 Million | -40.07 Million |
| Depreciation & Amortization | 19.56 Million | 14.92 Million | 6.5 Million | 4.27 Million | 8.38 Million | 4.45 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -42.05 Million | - | - | - | 18.1 Million | - |
| Other non-cash items | -35.89 Million | 19.66 Million | -38.14 Million | 9.66 Million | -98.1 Million | -59.48 Million |
| Investing Cash Flow | -324.81 Million | -49.04 Million | -340.87 Million | 28.84 Million | -88.69 Million | -151.82 Million |
| Investments in PPE | -104.2 Million | -55.13 Million | -57.44 Million | -61.76 Million | -128.75 Million | -82.7 Million |
| Acquisitions | -261.12 Million | 6.01 Million | -281.65 Million | 62.67 Million | 21.08 Million | -38.93 Million |
| Investment purchases | -1.57 Million | 79.56 Thousand | -1.77 Million | -56.68 Million | -77.42 Million | -30.18 Million |
| Sales/Maturities of investments | - | - | - | 84.62 Million | 75.41 Million | - |
| Other Investing Activities | 37.27 Million | - | -1.00 | -1.00 | 20.97 Million | -1.00 |
| Financing Cash Flow | 190.55 Million | 45.36 Million | 161.75 Million | 27.74 Million | 23.51 Million | 1.88 Million |
| Debt repayment | -196.73 Million | -47.75 Million | -164.78 Million | -28.97 Million | -20 Million | -4.4 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 5.1 Million | - | -3.03 Million | -1.23 Million | 43.51 Million | - |
| Accounts receivables | 2.14 Million | - | - | - | -15.06 Million | - |
| Accounts payables | - | - | - | - | 15.06 Million | - |
| Inventory | -21.15 Million | - | - | - | -14.73 Million | - |
| Other working capital | -793 Thousand | - | - | - | 32.84 Million | - |
| Cash at beginning of period | 1.33 Billion | 1.18 Billion | 1.49 Billion | 1.56 Billion | 1.52 Billion | 1.88 Billion |
| Cash at end of period | 943.21 Million | 1.03 Billion | 1.18 Billion | 1.49 Billion | 1.33 Billion | 1.56 Billion |
| Capital Expenditure | -104.2 Million | -55.13 Million | -57.44 Million | -61.76 Million | -128.75 Million | -82.7 Million |
| Effect of forex changes on cash | 12.56 Million | - | -16.68 Million | -23.67 Million | 62.9 Million | -60.57 Million |
| Net cash flow / Change in cash | -388.93 Million | -146.2 Million | -309.86 Million | -72.33 Million | -191.04 Million | -314.52 Million |
| Free Cash Flow | -371.44 Million | -191.17 Million | -171.49 Million | -167.01 Million | -317.52 Million | -186.71 Million |
CYB
SYNT
300033
YGTYF
301183
LEDIBOND